title: Psychiatrists' awareness of adherence to antipsychotic medication in patients with schizophrenia: results from a survey conducted across Europe, the Middle East, and Africa.
abstract: BACKGROUND
  Nonadherence is common among patients with schizophrenia, although the rates vary according to means of assessment and patient population. Failure to adhere to medication can have a major impact on the course of illness and treatment outcomes, including increasing the risk of relapse and rehospitalization. Understanding psychiatrists' perception of the causes and consequences of nonadherence is crucial to addressing adherence problems effectively.
  
  
  METHODS
  The Europe, the Middle East, and Africa (EMEA) Spanish Adherencia Terapéutica en la Esquizofrenia (ADHES) survey was conducted by questionnaire during January-March 2010 among psychiatrists treating patients with schizophrenia in 36 countries. The survey comprised 20 questions. In addition to recording the demographic details of the 4722 respondents (~12% response rate), it canvassed their preferred methods of assessing adherence, their perceptions of adherence rates, reasons for nonadherence, and strategies to improve adherence.
  
  
  RESULTS
  Psychiatrists estimated that 53% of their patients with schizophrenia were partially/nonadherent during the previous month. They estimated only one-third of patients who deteriorated after stopping medication were able to attribute this to nonadherence. Psychiatrists assessed adherence most often by patient interview. Lack of insight was viewed as the most important cause of medication discontinuation, followed by patients feeling better and thinking their medication unnecessary, and experiencing undesirable side effects. Considerably fewer psychiatrists viewed insufficient efficacy, cognitive impairment, or drug/alcohol abuse as the most important reasons for their patients stopping medication.
  
  
  CONCLUSIONS
  Psychiatrists throughout EMEA recognize the impact of partial/nonadherence to medication, with patient enquiry being the most commonly used means of assessment. There remains a need for more proactive management of patients with schizophrenia, particularly in increasing patient insight of their illness in order to improve adherence and minimize the consequences of relapse. Strategies focused on raising awareness of the importance of adherence are also warranted, with the aim of improving patient outcomes in schizophrenia.
authors: Department of Psychiatry, Hospital Meixoeiro, Complejo Hospitalario Universitario de Vigo, Vigo, Spain.
authors: José Manuel
authors: JM
authors: Olivares
authors: Köksal
authors: K
authors: Alptekin
authors: Jean-Michel
authors: JM
authors: Azorin
authors: Fernando
authors: F
authors: Cañas
authors: Vincent
authors: V
authors: Dubois
authors: Robin
authors: R
authors: Emsley
authors: Philip
authors: P
authors: Gorwood
authors: Peter M
authors: PM
authors: Haddad
authors: Dieter
authors: D
authors: Naber
authors: George
authors: G
authors: Papageorgiou
authors: Miquel
authors: M
authors: Roca
authors: Pierre
authors: P
authors: Thomas
authors: Guadalupe
authors: G
authors: Martinez
authors: Andreas
authors: A
authors: Schreiner
keywords: ADHES; adherence; psychiatrist; schizophrenia; survey
references: J Clin Psychiatry. 2000 May;61(5):382-6
references: 10847315
references: Schizophr Bull. 2006 Oct;32(4):724-42
references: 16707778
references: J Clin Psychiatry. 2003;64 Suppl 16:3-9
references: 14680412
references: Schizophr Bull. 2006 Oct;32(4):786-94
references: 16887889
references: Am J Psychiatry. 2011 Jun;168(6):603-9
references: 21362741
references: J Clin Psychiatry. 2003 Oct;64(10):1250-7
references: 14658976
references: Br J Psychiatry. 2003 Sep;183:197-206
references: 12948991
references: Psychiatry Res. 2010 Jan 30;175(1-2):58-62
references: 20004980
references: J Clin Psychiatry. 2002 Oct;63(10):892-909
references: 12416599
references: Actas Esp Psiquiatr. 2006 Nov-Dec;34(6):386-92
references: 17117335
references: BMC Psychiatry. 2006 Oct 18;6:42
references: 17049093
references: Nord J Psychiatry. 2006;60(2):114-20
references: 16635929
references: Clin Drug Investig. 2013 Feb;33(2):97-107
references: 23288695
references: J Clin Psychiatry. 2003 Nov;64(11):1308-15
references: 14658944
references: Clin Ther. 2008 Dec;30(12):2378-86
references: 19167596
references: J Clin Psychiatry. 2008 Jan;69(1):106-13
references: 18312044
references: Psychiatry Res. 2008 Nov 30;161(2):235-47
references: 18849080
references: Psychiatr Serv. 1998 Feb;49(2):196-201
references: 9575004
references: Schizophr Res. 2002 Oct 1;57(2-3):209-19
references: 12223252
references: J Clin Psychiatry. 2009;70 Suppl 4:1-46; quiz 47-8
references: 19686636
references: Prim Care Companion J Clin Psychiatry. 2009;11(4):147-54
references: 19750066
references: Psychiatry Res. 2010 Apr 30;176(2-3):109-13
references: 20185182
references: Compr Psychiatry. 2004 Jan-Feb;45(1):16-9
references: 14671732
references: Expert Rev Neurother. 2009 Jul;9(7):1035-43
references: 19589052
references: Can J Psychiatry. 2009 Jan;54(1):28-35
references: 19175977
references: Eur Psychiatry. 2002 May;17(3):148-54
references: 12052575
references: Prog Neuropsychopharmacol Biol Psychiatry. 2002 Dec;26(7-8):1229-33
references: 12502008
references: Psychiatr Serv. 2007 Sep;58(9):1187-92
references: 17766564
references: J Clin Psychiatry. 2006;67 Suppl 5:9-14
references: 16822091
references: Value Health. 2009 Jun;12(4):536-43
references: 19900255